Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
Fizazi, Karim, Prof, Carducci, Michael, MD, Smith, Matthew, MD, Damião, Ronaldo, Prof, Brown, Janet, MD, Karsh, Lawrence, MD, Milecki, Piotr, MD, Shore, Neal, MD, Rader, Michael, MD, Wang, Huei, PhD, Jiang, Qi, PhD, Tadros, Sylvia, MPH, Dansey, Roger, MD, Goessl, Carsten, MD
Published in The Lancet (British edition) (05.03.2011)
Published in The Lancet (British edition) (05.03.2011)
Get full text
Journal Article
Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial
Smith, Matthew R, Prof, Saad, Fred, Prof, Coleman, Robert, Prof, Shore, Neal, MD, Fizazi, Karim, Prof, Tombal, Bertrand, Prof, Miller, Kurt, Prof, Sieber, Paul, MD, Karsh, Lawrence, MD, Damião, Ronaldo, Prof, Tammela, Teuvo L, Prof, Egerdie, Blair, MD, Van Poppel, Hendrik, Prof, Chin, Joseph, Prof, Morote, Juan, Prof, Gómez-Veiga, Francisco, MD, Borkowski, Tomasz, Prof, Ye, Zhishen, PhD, Kupic, Amy, MA, Dansey, Roger, MD, Goessl, Carsten, MD
Published in The Lancet (British edition) (2012)
Published in The Lancet (British edition) (2012)
Get full text
Journal Article
Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study
Thomas, David, Dr, Henshaw, Robert, MD, Skubitz, Keith, Prof, Chawla, Sant, MD, Staddon, Arthur, Prof, Blay, Jean-Yves, Prof, Roudier, Martine, MD, Smith, Judy, BA, Ye, Zhishen, PhD, Sohn, Winnie, PhD, Dansey, Roger, MD, Jun, Susie, MD
Published in The lancet oncology (01.03.2010)
Published in The lancet oncology (01.03.2010)
Get full text
Journal Article